Senzime wins CE Mark for TetraGraph neuromoscular monitor
Kort samengevat
German patient monitor developer Senzime said today it won CE Mark approval in the European Union for its TetraGraph neuromuscular monitor. The newly cleared TetraGraph monitor is designed for use in the perioperative monitoring of physiologic data in surgical patients under general anesthesia and muscle relaxation using neuromuscular blocking drugs. The system is designed to […]
Verder lezen bij de bron
Bekijk het volledige nieuwsbericht rechtstreeks bij MassDevice.
Lees het volledige bericht ↗